Eric H. Schoenstein
Jensen Investment Management
Jensen Investment Management 13F holdings
Eric H. Schoenstein's Portfolio
- Portfolio value:
- $6.36B≈
- # of securities:
- 89
- Reported for:
- 31 Dec 2025 (Q4)
- Latest filing date:
- 11 Feb 2026
What was Eric H. Schoenstein's 2025 Q4 portfolio?
Jensen Investment Management has disclosed a total of 89 security holdings in their (2025 Q4) SEC 13F filing(s) with portfolio value of $6,355,926,761.
Jensen Investment Management's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Eric H. Schoenstein's original 13F reports (2025 Q4) are the official SEC institutional disclosure documents covering all reported equity positions.
89 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Microsoft Corp
|
10.10%
|
1,326,840
|
$483.62
|
+4.09%($503.40)
|
$641,686,361
|
2013 Q2 or earlier
|
≈ 12.75+ years
|
Common Stock
|
-12.68% (-192.61K)
|
-1.16%
|
|
|
|
Apple Inc
|
8.46%
|
1,978,272
|
$271.86
|
+15.57%($314.19)
|
$537,813,026
|
2015 Q2
|
≈ 10.75 years
|
Common Stock
|
-14.11% (-324.98K)
|
-1.1%
|
|
|
|
Alphabet Inc, CL-A
|
7.55%
|
1,532,213
|
$313.00
|
+13.30%($354.63)
|
$479,582,669
|
2016 Q3
|
≈ 9.50 years
|
Common Stock
|
-14.46% (-259.1K)
|
-1.01%
|
|
|
|
NVIDIA Corp
|
6.61%
|
2,253,736
|
$186.50
|
+19.52%($222.91)
|
$420,321,764
|
2025 Q2
|
≈ 0.75 years
|
Common Stock
|
+4.33% (+93.47K)
|
+0.27%
|
|
|
|
Mastercard Inc
|
4.34%
|
482,740
|
$570.88
|
-0.79%($566.37)
|
$275,586,611
|
2015 Q3
|
≈ 10.50 years
|
Common Stock
|
-16.99% (-98.79K)
|
-0.7%
|
|
|
|
Eli Lilly and Company
|
4.22%
|
249,827
|
$1,074.68
|
+10.73%($1,189.97)
|
$268,484,080
|
2025 Q2
|
≈ 0.75 years
|
Common Stock
|
-46.13% (-213.91K)
|
-2.85%
|
|
|
|
Amazon.com Inc
|
4.12%
|
1,133,670
|
$230.82
|
+19.96%($276.89)
|
$261,673,709
|
2025 Q4
|
≈ 0.25 years
|
Common Stock
|
new
|
+4.12%
|
|
|
|
Stryker Corp
|
4.05%
|
731,545
|
$351.47
|
-3.58%($338.88)
|
$257,116,121
|
2013 Q2 or earlier
|
≈ 12.75+ years
|
Common Stock
|
-40.04% (-488.5K)
|
-2.13%
|
|
|
|
Meta Platforms Inc
|
3.80%
|
366,040
|
$660.09
|
-9.59%($596.80)
|
$241,619,344
|
2025 Q2
|
≈ 0.75 years
|
Common Stock
|
-8.47% (-33.89K)
|
-0.28%
|
|
|
|
Abbott Laboratories
|
3.69%
|
1,873,063
|
$125.29
|
-14.24%($107.45)
|
$234,676,063
|
2013 Q2 or earlier
|
≈ 12.75+ years
|
Common Stock
|
-22.26% (-536.37K)
|
-0.83%
|
|
Completely sold out
5 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
Zoetis Inc
|
-883,924
|
-1.6%
|
2024 Q1
|
≈ 1.75 years
|
|
|
|
United Parcel Service Inc
|
-20,000
|
-0.02%
|
2013 Q2 or earlier
|
≈ 12.50+ years
|
|
|
|
Bristol-Myers Squibb Company
|
-26,475
|
-0.01%
|
2015 Q1
|
≈ 10.75 years
|
|
|
|
Paychex Inc
|
-9,320
|
-0.01%
|
2013 Q2 or earlier
|
≈ 12.50+ years
|
|
|
|
Kellanova
|
-6,372
|
-0.01%
|
2024 Q1
|
≈ 1.75 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.